Literature DB >> 10418011

["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].

P Sednaoui1, B el Mantih, M Cauwell.   

Abstract

UNLABELLED: Clostridium difficile is a sporulated obligate anaerobe responsible for most cases of antibiotic-associated colitis, for 15 to 25% of cases of antibiotic-related diarrhea, and for a substantial proportion of nosocomial infections. The most important laboratory test for the diagnosis of C. difficile infection is examination of the stool for C. difficile toxins A and/or B. Detection of cytotoxin B using the direct cytotoxicity assay (D-CA) is the gold standard test. Whether routine isolation of the organism from stool is warranted remains controversial.
OBJECTIVES: To evaluate second-look CA done on C. difficile culture-positive filtrates from stool samples negative by the D-CA.
METHODS: 300 consecutive stool samples sent to the Alfred Fournier Institute from April through October 1998 for a CA were routinely cultured on modified Cefoxitin Cycloserine Fructose Agar medium (CCFA). All CA-negative samples that grew C. difficile were examined by second-look CA.
RESULTS: 245 stool specimens (81.7%) were negative by both CA and culture. The remaining 55 specimens all yielded C. difficile by culture; 32 (58.2%) had a positive D-CA and nine (16.4%) a negative D-CA with a positive second-look CA done on culture filtrates.
CONCLUSION: Our data suggest that stool specimens sent for a direct CA should be routinely cultured to provide material for a second-look CA on culture-positive filtrates if the first CA prove negative. Culturing also allows to study antimicrobial drug resistance phenotypes and epidemiological markers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10418011

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  5 in total

1.  In vitro activity of linezolid against Clostridium difficile.

Authors:  T Peláez; R Alonso; C Pérez; L Alcalá; O Cuevas; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  The evolution of acetyl-CoA synthase.

Authors:  P A Lindahl; B Chang
Journal:  Orig Life Evol Biosph       Date:  2001 Aug-Oct       Impact factor: 1.950

3.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Comparison of ImmunoCard Toxins A&B and the new semiautomated Vidas Clostridium difficile Toxin A&B tests for diagnosis of C. difficile infection.

Authors:  Luis Alcalá; Mercedes Marín; María Madrid; Esther Domínguez-García; Pilar Catalán; María Teresa Peláez; Mar Sánchez-Somolinos; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

5.  Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens.

Authors:  L Alcalá; L Sánchez-Cambronero; M P Catalán; M Sánchez-Somolinos; M T Peláez; M Marín; E Bouza
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.